Makers Lab Peer Comparison

BSE: 506919

₹206.11

₹-8.38 (-3.91%)

As on 27-Aug-2026IST

Market cap

₹122 Cr

Revenue (TTM)

₹148 Cr

P/E Ratio

35.6

P/B Ratio

1.6

Div. Yield

0 %

Edit

	Makers Lab	Pfizer	Caplin Point Lab	Astrazeneca Pharma	Eris Lifesciences
Market cap (₹ Cr)	122	21,703	19,323	17,803	18,177
Revenue (₹ Cr)	148	2,570	2,287	2,432	3,230
Net Profit (₹ Cr)	11.17	735.15	678.07	169.62	666.92
Net Margin (%)	7.43	26.88	28.10	6.90	20.60
RoE (%)	4.76	19.16	19.73	20.76	18.75
Price to Earnings	35.57	29.52	29.04	104.96	28.23
Price-To-Book	1.57	4.92	5.13	19.69	4.49

Income Statement (₹ Cr)

	Makers Lab	Pfizer	Caplin Point Lab	Astrazeneca Pharma	Eris Lifesciences
Operating Revenue	140.59	2,519.65	1,937.47	2,275.58	2,893.64
Total Income	142.30	2,707.60	2,033.90	2,304.07	2,912.00
Total Expenditure	125.78	1,615.47	1,290.54	2,013.55	1,876.44
EBITDA	14.82	904.18	646.93	262.03	1,017.20
Depreciation	4.53	57.73	65.96	28.58	315.46
EBIT	10.29	846.45	580.97	233.45	701.74
Interest	0.85	9.57	0.61	4.49	231.29
Other Income	1.71	187.95	96.43	28.49	18.36
Exceptional Items	-0.79	-49.16	--	-5.25	--
Profit before Tax	11.15	975.67	676.78	252.20	488.87
Provision for Tax	3.29	253.24	135.69	64.68	114.20
Profit after Tax	7.86	722.43	541.09	187.52	374.67

	Makers Lab	Pfizer	Caplin Point Lab	Astrazeneca Pharma	Eris Lifesciences
Shareholder's Funds	72.92	4,202.90	2,850.49	872.79	2,854.36
Minority Interest	49.55	--	35.90	--	417.40
Non-Current Liabilities	10.12	19.19	13.24	394.49	2,100.97
Current Liabilities	34.02	627.48	305.99	1,109.50	1,489.55
Total Liabilities	166.62	4,921.88	3,207.85	2,414.58	6,862.28

	Makers Lab	Pfizer	Caplin Point Lab	Astrazeneca Pharma	Eris Lifesciences
Non-Current Assets	79.67	1,046.35	1,071.67	509.16	5,531.13
Current Assets	86.95	3,803.22	2,133.95	1,859.88	1,331.15
Total Assets	166.62	4,921.88	3,207.85	2,414.58	6,862.28
Total Debt*	4.76	2.50	0.55	0.00	2,421.66
Net Current Assets	52.93	3,175.74	1,827.96	750.38	-158.40
Contingent Liabilities	4.71	370.49	0.64	121.23	64.29

	Makers Lab	Pfizer	Caplin Point Lab	Astrazeneca Pharma	Eris Lifesciences
Cash From Operating Activities	14.29	967.57	432.37	-15.14	1,065.01
Cash Flow from Investing Activities	-14.69	-561.67	-334.73	18.69	-79.97
Cash from Financing Activities	0.35	-798.31	-38.32	-91.97	-881.32
Net Cash Inflow / Outflow	-0.05	-392.41	59.32	-88.42	103.72

	Makers Lab	Pfizer	Caplin Point Lab	Astrazeneca Pharma	Eris Lifesciences
ROCE (%)	15.83	23.39	26.22	31.24	13.59
ROE (%)	10.96	17.16	21.72	23.02	13.81
ROA (%)	5.00	14.91	18.37	8.90	5.48
EBIT Margin (%)	11.76	43.34	38.37	12.77	35.79
Net Margin (%)	5.52	26.68	26.60	8.14	12.87
Cash Profit Margin (%)	8.81	29.72	31.33	9.47	23.22

	Makers Lab	Pfizer	Caplin Point Lab	Astrazeneca Pharma	Eris Lifesciences
Revenue Growth (%)	16.43	10.45	14.37	32.59	44.02
EBIT Growth (%)	-18.48	19.68	20.21	-1.38	48.22
Net Profit Growth (%)	-27.93	-5.88	17.27	62.02	-5.65
EPS Growth (%)	-68.61	-5.88	17.25	62.02	-10.39
Book Value Growth (%)	3.43	-0.34	23.77	13.51	10.19

	Makers Lab	Pfizer	Caplin Point Lab	Astrazeneca Pharma	Eris Lifesciences
Price / Earnings	33.93	29.89	28.38	103.45	54.83
Price / Book Value	1.09	5.14	5.52	22.39	6.78
Dividend Yield (%)	0.00	1.59	0.30	0.46	0.52
EV/EBITDA	5.08	16.93	19.78	65.23	20.75
Market Cap (₹ Cr)	79.77	21,592.90	15,219.80	19,398.64	19,292.77

	Makers Lab	Pfizer	Caplin Point Lab	Astrazeneca Pharma	Eris Lifesciences
Debt to Equity	0.07	0.00	0.00	0.00	0.85
Short term debt to equity ratio	0.04	0.00	0.00	--	0.14
Current Ratio	2.56	6.06	6.97	1.68	0.89
Quick Ratio	1.23	5.31	5.88	0.75	0.67
Interest Coverage	14.11	102.95	1,110.48	57.17	3.11

	Makers Lab	Pfizer	Caplin Point Lab	Astrazeneca Pharma	Eris Lifesciences
Debtors to sales (%)	14.13	7.22	32.65	9.39	15.85
Asset Turnover	0.89	0.54	0.66	1.08	0.43
Receivable days	62.18	26.06	110.70	31.88	54.07
Inventory Days	102.52	65.95	65.86	126.03	32.16
Payable days	90.08	81.01	105.88	163.79	140.91
Cash Conversion Cycle	74.62	11.00	70.68	-5.88	-54.68

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.